Introduction. -MRP2/Mrp2 (ABCC2, cMOAT) is a member of the ABC transporter family, a group of proteins using the energy of ATP to transport molecules across cell membranes. MRP2/Mrp2 is expressed in various tissues, including the liver, the kidneys, and the intestine. The transporter is localized at the apical membrane of polarized epithelial cells in these tissues. Probably, its most important role is in the biliary elimination of various endogenous and exogenous anions. These anions are structurally diverse; they can be both conjugates and unconjugated anions.In 2003, two groups simultaneously found that estradiol-17b-glucuronide (E 2 17bG) transport mediated by human MRP2 has positive cooperativity [1] [2]. These laboratories observed a rather sigmoid curve when investigating the concentration dependence of E 2 17bG transport. This phenomenon is due to the existence of at least two binding sites of MRP2. The Hill number of the linearized saturation curves was > 1.5, confirming the presence of multiple binding sites. These sites can interact with each other, e.g., if a modulator compound binds to one of the sites, it is able to stimulate the transport of E 2 17bG or other substrates. E 2 17bG is a cholestatic endogenous estradiol metabolite, causing reversible, dosedependent cholestasis [3]. The mechanism of E 2 17bG-induced cholestasis is multifactorial: it induces endocytic internalization of BSEP and MRP2 proteins [4] [5] and increases paracellular permeability [6]. In addition, E 2 17bG inhibits the transport of bile salts by Bsep via trans-inhibition [7]. Transport by MRP2/Mrp2, thus, contributes to the cholestatic activity of E 2 17bG, making this transport physiologically and pharmacologically even more important.In the present minireview, we give an overview of recent studies focusing on the interactions of MRP2/Mrp2 with E 2 17bG. The review is organized according to the experimental approaches used. In vitro -in vivo correlations (IVIVC) and speciesspecificity aspects will also be covered.